#$%^&*AU2018201986A120180412.pdf#####CRYSTALLINE BROMODOMAIN INHIBITORS ABSTRACT N- [4-(2,4-difluorophenoxy)-3 -(6-methyl-7-oxo-6,7-dihydro- 1 H-pyrrolo [2,3 -c]pyridin-4yl)phenyl]ethanesulfonamide and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.